研究文章
干扰素的作用在BCG耐火Nonmuscle浸润性膀胱癌的管理
表2
病人和肿瘤病理特征之间BCG /干扰素失败和nonfailures。
|
|
失败 |
Nonfailures |
价值 |
|
| 没有 |
25 |
56.8% |
19 |
43.2% |
|
| 男性 |
18 |
40.9% |
17 |
38.6% |
0.15 |
| 女 |
7 |
15.9% |
2 |
4.5% |
0.15 |
| 时间BCG失败 |
|
|
|
|
|
| < 6个月 |
16 |
36.4% |
4 |
9.1% |
0.0046 |
| 6 - 12个月 |
6 |
13.6% |
6 |
13.6% |
0.5 |
| 12 - 24个月 |
1 |
2.3% |
5 |
11.4% |
0.84 |
| > 24个月 |
6 |
13.6% |
4 |
9.1% |
0.21 |
| 病理学在感应 |
|
|
|
|
|
| 这 |
7 |
15.9% |
8 |
18.2% |
0.33 |
| 助教 |
10 |
22.7% |
5 |
11.4% |
0.27 |
| T1 |
8 |
18.2% |
6 |
13.6% |
0.44 |
| 年级感应 |
|
|
|
|
|
| HG |
22 |
50.0% |
17 |
38.6% |
0.93 |
| LG |
3 |
6.8% |
2 |
4.5% |
0.93 |
| 肿瘤大小 |
|
|
|
|
|
| < 1厘米 |
7 |
15.9% |
6 |
13.6% |
0.79 |
| 1 - 5厘米 |
16 |
36.4% |
12 |
27.3% |
0.95 |
| > 5厘米 |
2 |
4.5% |
1 |
2.3% |
0.72 |
| Multifocality |
|
|
|
|
|
| 是的 |
11 |
25.0% |
6 |
13.6% |
0.4 |
| Hx吸烟 |
16 |
36.4% |
12 |
27.3% |
0.95 |
|
|
